Skip to main content
. 2022 Oct 30;79(2):365–375. doi: 10.1007/s12020-022-03232-3

Table 2.

Echocardiography parameters

Characteristics Acromegaly patients
(n = 129)
Healthy controls
(n = 80)
Newly diagnosed acromegaly patients
(n = 27)
Uncontrolled
Acromegaly
(n = 53)
Controlled
Acromegaly
(n = 49)
Acromegaly patients vs. healthy controls
P-value
Group comparison
P-value
Ao. Asc. (mm) 33.7 ± 3.4 32.7 ± 2.8 34.4 ± 1.8 33.1 ± 3.8 33.8 ± 3.2 NS

<0.007c

NSa,b,d,e,f

LAVI (ml/m2) 38.4 ± 7.2 29.1 ± 6.1 39.2 ± 6.8 36.9 ± 6.5 32.4 ± 5.2 <0.001

<0.001c,e

0.018b

0.042d

NSa,f

LVEDd (mm) 50.5 ± 5.8 48.5 ± 2.2 53.7 ± 9.4 51.1 ± 4.0 48.6 ± 3.5 NS

<0.001c

0.006b

NSa,f,d,e

RVEDd (mm) 32.8 ± 3.8 31.4 ± 2.3 31.2 ± 3.9 31.7 ± 2.6 32.4 ± 2.9 NS NS
IVSDd (mm) 12.4 ± 2.1 10.1 ± 1.0 13.5 ± 2.3 13.2 ± 1.7 10.9 ± 1.2 <0.001

<0.001b,c,d,e,f

NSa

PWDd (mm) 11.6 ± 2.0 9.5 ± 1.0 13 ± 2.5 12.3 ± 1.5 10.2 ± 1.1 <0.001

<0.001b,c,d,e,f

NSa

LVM (g) 248 ± 108 159 ± 28 324 ± 174 268 ± 71 185 ± 37 <0.001

<0.001b,c,d,e,f

NSa

LVMI (g/m2) 123 ± 45 83 ± 16 154 ± 72 133 ± 29 96 ± 19 <0.001

<0.001b,c,d,e,f

NSa

LVH (%) 67% 18% 81% 83% 43% <0.001

<0.00b,c,d,e,f

NSa

RWT > 0.42 (%) 78 35 93 89 73 <0.001

<0.001b,c,d,e

0.039f

NSa

LVEF (%) 58 ± 6 57 ± 3 54 ± 10 58 ± 5 59 ± 3 NS

0.039b

NSa,c,d,e,f

E/E´ 10.9 ± 3.62 9.2 ± 3.11 11.0 ± .5.46 10.4 ± .4.35 9.6 ± 3.94 0.003

0.012c

0.029b

0.038e

NSa,d,f

E/A 0.95 ± 0.4 1.15 ± 0.3 0.9 ± 0.35 1.0 ± 0.3 1.10 ± 0.5 0.001

0.008c

0.027b

NSa,d,e,f

TAPSE (mm) 22.2 ± 2.9 22.5 ± 1.1 22.3 ± 2.6 22.1 ± 3.2 22.3 ± 2.7 NS NS
Valvopathy (%) 43 10 67 38 35 <0.001

<0.001c,e,f

0.007b

0.014a

NSd

Data is presented as mean ±standard deviation (SD) and as percentage

Level of significance was set at *p ≤ 0.05

Ao. Asc. ascending aorta, LAVI left atrial volume index, LVEDd left ventricular end-diastolic parameter, RVEDd right ventricular end-diastolic parameter, IVSDd interventricular septum diastolic diameter, PWDd posterior wall diastolic diameter, LVM left ventricular mass, LVMI left ventricular mass index, LVH left ventricle hypertrophy, RWT relative wall thickness, LVEF left ventricular ejection fraction, E/E´ mitral E-wave velocity divided by mitral annular velocity, E/A mitral E-wave divided by mitral A-wave velocity, TAPSE tricuspid annular plane systolic excursion

aNewly diagnosed acromegaly patients vs. uncontrolled

bNewly diagnosed acromegaly patients vs. controlled

cNewly diagnosed acromegaly vs. healthy controls

dUncontrolled vs. controlled

eUncontrolled vs. healthy controls

fControlled vs. healthy controls